Small Pharmaceuticals

Unichem Laboratories Ltd.

UNICHEMLAB

Market Cap
₹4,025 Cr.
P/E
15.92

Unichem Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
4,025 Cr
PE
PE
15.92
Prom Holding
Prom Holding
70.22 %
ROE (%)
ROE (%)
9.30
ROCE (%)
ROCE (%)
4.33
Div Yield (%)
Div Yield (%)
-
Sales
Sales
2,201 Cr
OPM (%)
OPM (%)
-
Debt to Equity
Debt to Equity
0.17
Institutions
Institutions
11.63 %
Individual < 2 lac
Individual < 2 lac
13.35 %
No. of Shareholders
No. of Shareholders
23,386
View more
Edit Ratio's

About

Unichem Laboratories Limited, founded in 1962, is a renowned manufacturer of pharmaceutical fo… Read more
Low
278
52W Range
High
658
  • Unichem Laboratories
  • Guj. Themis Biosyn
  • Gufic Biosciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

5 %
(as of Mar 18)
Historic
Ampoxin - Market Share
5 %
(as of Mar 18)
Historic
Olsar - Market Share
3 %
(as of Mar 18)
Historic
Telsar - Market Share
16 %
(as of Mar 18)
Historic
Unienzyme - Market Share
6 %
(as of Mar 18)
Historic
Vizlac - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • GMM Pfaudler Ltd.
    • Kilitch Drugs (India) Ltd.

    FAQs on Unichem Laboratories Ltd. Business

    Unichem Laboratories Limited, a leading pharmaceutical company established in 1962, specializes in manufacturing formulations, APIs, and generic medicines. With over 7 decades of experience, it focuses on supplying affordable medicines globally.

    Unichem Laboratories major competitors are Guj. Themis Biosyn, Gufic Biosciences, Novartis India, Panacea Biotec, Zota Health Care, Orchid Pharma, Kwality Pharma.
    Market Cap of Unichem Laboratories is ₹4,025 Crs.
    While the median market cap of its peers are ₹3,809 Crs.

    Unichem Laboratories seems to be less financially stable compared to its competitors.
    Altman Z score of Unichem Laboratories is 4.67 and is ranked 8 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Unichem Laboratories Ltd.
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material